![](/img/cover-not-exists.png)
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis
Ivan R Schwab, Mitchell Friedlaender, James McCulley, Steven J Lichtenstein, C.Thomas MoranVolume:
110
Year:
2003
Language:
english
DOI:
10.1016/s0161-6420(02)01894-8
File:
PDF, 386 KB
english, 2003